サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1477132

粒子線療法市場：製品タイプ別、サービス別、がんタイプ別、システム別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測

Particle Therapy Market, By Product Type, By Service, By Cancer Type, By System, By End-User By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
粒子線療法市場：製品タイプ別、サービス別、がんタイプ別、システム別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

粒子線療法市場規模は2023年に7億340万米ドルとなり、2024～2032年にかけてCAGR 8.83%で拡大

粒子線療法市場-市場力学

がん患者の急増が粒子線療法市場の成長を促進すると予測

高齢化や喫煙、食生活の乱れ、運動不足といった不健康なライフスタイルの選択などの要因により、がんの有病率は世界的に上昇傾向にあります。その結果、粒子線療法のような効果的な治療オプションに対する需要が高まっています。米国国立保健統計センターのデータによると、2023年には米国だけで195万8,310人の新規がん患者と60万9,820人のがん関連死亡者が出ると予測されています。治療計画ソフトウェア、ビーム照射システム、イメージング技術の強化を含む粒子線療法技術の継続的な進歩は、市場に有望な機会を提供しています。しかし、治療費の高さが市場成長の課題となる可能性があります。

粒子線療法市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024～2032年）に約8.83%のCAGRで毎年成長すると推定されます。

製品タイプ別では、陽子線療法が2023年に最大の市場シェアを示すと予測されています。

サービス別では、サイクロトロンが2023年の主要タイプでした。

がんタイプ別では、小児がんが2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

粒子線療法市場-セグメンテーション分析：

世界の粒子線療法市場は、製品タイプ、サービス、がんタイプ、システム、エンドユーザー、地域に基づいて区分されます。

市場は製品タイプによって2つのグループに区分される：陽子線療法と重粒子線療法です。陽子線療法が市場の大半のシェアを占めています。近年、粒子線療法、特に陽子線療法はがん治療のセグメントで大きな関心を集めています。世界のがん罹患率の増加に伴い、陽子線療法のような正確で効率的ながん治療法に対するニーズが高まっています。

市場はサービス別に3つのカテゴリーに区分される：サイクロトロン、シンクロトロン、シンクロサイクロトロンです。サイクロトロンは、がん治療用の陽子ビームの生成を容易にすることで、粒子線療法セグメントで重要な役割を果たしており、市場を牽引しています。

市場は、がんタイプによって3つのセクションに分類される：小児がん、前立腺がん、肺がん、乳がん、脳・脊髄がん、その他です。小児がんが市場で最大のシェアを占めています。小児がんに関する認知度向上に注力する患者支援団体や組織は、粒子線療法などの先進的な治療選択肢を提唱する上で重要な役割を果たしています。彼らの努力は、小児がん治療のための粒子線療法の利点に関する家族や医療プロバイダーの意識の向上に貢献しています。

粒子線療法市場は、提供されるサービスタイプによって3つのグループに分類される：マルチルームシステムとシングルルームシステムです。マルチルームシステムとシングルルームシステムはいずれも、独自の利点を提供し、多様な医療環境と患者集団に対応するため、粒子線療法市場において重要な意義を持っています。

粒子線療法市場は、エンドユーザーによって、病院、クリニック、外来手術センター、その他の3つに区分されます。この市場に多様なエンドユーザーが存在することは、先進的ながん治療の選択肢が広く受け入れられ、ニーズが高まっていることを意味します。このことが、さまざまな医療環境における市場の成長と発展を後押ししています。

粒子線療法市場-地理的洞察

この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに地理的に広がっています。これらの地域は、事業活動を行っている国に基づいてさらに分けられます。北米地域が市場を独占しているのは、メーカーによる資金調達や投資が増加していることに加え、政府が治療センターの設立に力を入れているためです。粒子線療法システムと関連技術のメーカーは、粒子線療法の能力と利用しやすさを向上させるため、研究開発に多額の投資を行っています。U.S. Investments in Medical and Health Research and Developmentによると、この産業は2020年の米国の研究開発における医療健康投資のほぼ3分の2（66％）を占め、1,618億米ドルに達します。欧州は、主に粒子線療法センターの増加により、市場成長において2番目に大きな地域を占めています。

粒子線療法市場-競合情勢：

粒子線療法市場の競合情勢は、技術の進歩によって左右されます。各社は粒子線療法システムの有効性、生産性、安全性を高めるための研究開発に重点的に投資しています。さらに、この市場の競争は市場リーチと流通チャネルの影響を受けています。各メーカーは、販売サービス網を強化し、医療機関と提携を結び、粒子線療法システムの展開と維持に関する契約を確保することで、世界の足跡の拡大を競っています。めまぐるしく変化し続けるこの市場で優位に立つために、メーカーとサービスプロバイダーは常に他社との差別化を図り、競争上の優位性を獲得する方法を模索しています。

目次

第1章 粒子線療法市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 粒子線療法の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 粒子線療法産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 粒子線療法市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 粒子線療法市場情勢

  • 粒子線療法市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存参入企業の分析
    • 新興参入企業の分析

第7章 粒子線療法市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 陽子線療法
    • 重粒子線療法

第8章 粒子線療法市場-サービス別

  • 概要
    • サービス別セグメントシェア分析
    • サイクロトロン
    • シンクロトロン
    • シンクロサイクロトロン

第9章 粒子線療法市場-がんタイプ別

  • 概要
    • がんタイプ別セグメントシェア分析
    • 小児がん
    • 前立腺がん
    • 肺がん
    • 乳がん
    • 脳と脊髄のがん
    • その他

第10章 粒子線療法市場-システム別

  • 概要
    • システム別セグメントシェア分析
    • マルチルームシステム
    • シングルルームシステム

第11章 粒子線療法市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • クリニック
    • 外来手術センター
    • その他

第12章 粒子線療法市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカ主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析-粒子線療法業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Danfysik A/S
    • Hitachi, Ltd.
    • IBA
    • Mevion Medical Systems.
    • Optivus Proton Therapy, Inc.
    • ProTom International.
    • Provision Healthcare.
    • Sumitomo Heavy Industries, Ltd.
    • Siemens Healthcare GmbH
    • Others

第14章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Particle Therapy Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Particle Therapy Market, by Product Type 2019-2032 (USD Million)
  • TABLE Particle Therapy Market: Service Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Service
  • TABLE Global Particle Therapy Market, by Service 2019-2032 (USD Million)
  • TABLE Particle Therapy Market: Cancer Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cancer Type
  • TABLE Global Particle Therapy Market, by Cancer Type 2019-2032 (USD Million)
  • TABLE Particle Therapy Market: System Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by System
  • TABLE Global Particle Therapy Market, by System 2019-2032 (USD Million)
  • TABLE Particle Therapy Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Particle Therapy Market, by End User 2019-2032 (USD Million)
  • TABLE Particle Therapy Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Particle Therapy Market, by Region 2019-2032 (USD Million)
  • TABLE North America Particle Therapy Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Particle Therapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Particle Therapy Market, by Service, 2019-2032 (USD Million)
  • TABLE North America Particle Therapy Market, by Cancer Type, 2019-2032 (USD Million)
  • TABLE North America Particle Therapy Market, by System, 2019-2032 (USD Million)
  • TABLE North America Particle Therapy Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Particle Therapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Particle Therapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Particle Therapy Market, by Service, 2019-2032 (USD Million)
  • TABLE Europe Particle Therapy Market, by Cancer Type, 2019-2032 (USD Million)
  • TABLE Europe Particle Therapy Market, by System, 2019-2032 (USD Million)
  • TABLE Europe Particle Therapy Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Particle Therapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Particle Therapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Particle Therapy Market, by Service, 2019-2032 (USD Million)
  • TABLE Asia Pacific Particle Therapy Market, by Cancer Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Particle Therapy Market, by System, 2019-2032 (USD Million)
  • TABLE Asia Pacific Particle Therapy Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Particle Therapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Particle Therapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Particle Therapy Market, by Service, 2019-2032 (USD Million)
  • TABLE Latin America Particle Therapy Market, by Cancer Type, 2019-2032 (USD Million)
  • TABLE Latin America Particle Therapy Market, by System, 2019-2032 (USD Million)
  • TABLE Latin America Particle Therapy Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Particle Therapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Particle Therapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Particle Therapy Market, by Service, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Particle Therapy Market, by Cancer Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Particle Therapy Market, by System, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Particle Therapy Market, by End User, 2019-2032 (USD Million)
目次
Product Code: ANV2529

REPORT HIGHLIGHT

Particle Therapy Market size was valued at USD 703.40 Million in 2023, expanding at a CAGR of 8.83% from 2024 to 2032.

Particle therapy is a specialized type of radiation therapy that offers potential advantages over conventional radiation therapy for certain patients and conditions. It involves the use of beams of radiation containing heavy particles, such as protons and carbon ions, as a form of external beam radiation therapy. This treatment approach is particularly effective for tumors located near critical structures like the brain or spine, and that have not metastasized to other parts of the body. Particle therapy may be particularly beneficial for young patients, as it reduces the risk of harming healthy, growing tissue and minimizes the long-term side effects associated with radiation therapy. By utilizing highly charged particles, particle therapy delivers a smaller dose of radiation along its path to the tumor, ensuring that the majority of the radiation is concentrated on the tumor itself before dissipating almost entirely.

Particle Therapy Market- Market Dynamics

Surge in number of cancer patients is projected to boost particle therapy market growth

The prevalence of cancer is on the rise globally due to factors such as the aging population and unhealthy lifestyle choices like smoking, poor diet, and lack of physical activity. As a result, there is an increasing demand for effective treatment options like particle therapy. According to data from the National Center for Health Statistics, it is projected that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States alone. The continuous advancements in particle therapy technology, including enhancements in treatment planning software, beam delivery systems, and imaging techniques, offer promising opportunities for the market. However, the high cost of treatment may pose a challenge to the growth of the market.

Particle Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.83% over the forecast period (2024-2032)

Based on product type segmentation, Proton Therapy was predicted to show maximum market share in the year 2023

Based on Service segmentation, Cyclotrons was the leading type in 2023

Based on Cancer Type segmentation, Pediatric Cancer was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Particle Therapy Market- Segmentation Analysis:

The Global Particle Therapy Market is segmented on the basis of Product Type, Service, Cancer Type, System, End-User and Region.

The market is segmented into two groups according to the type of product: Proton Therapy and Heavy Ion Therapy. Proton Therapy holds the majority share in the market. In recent years, particle therapy, especially proton therapy, has garnered considerable interest in the field of cancer treatment. With the increasing global incidence of cancer, there is a rising need for accurate and efficient cancer treatment methods such as proton therapy.

The market is segmented into three categories according to Service: Cyclotrons, Synchrotrons, and Synchrocyclotrons. Cyclotrons are the leading force in the market, playing a crucial role in the particle therapy sector by facilitating the generation of proton beams for cancer therapy.

The market is categorized into three sections according to the type of cancer: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain and Spinal Cord Cancer, and Others. Pediatric Cancer holds the largest share in the market. Patient advocacy groups and organizations that focus on raising awareness about pediatric cancer play a vital role in advocating for advanced treatment options such as particle therapy. Their endeavors contribute to increasing awareness among families and healthcare providers regarding the advantages of particle therapy for treating pediatric cancer.

The particle therapy market is categorized into three distinct groups according to the type of service provided: Multi-Room Systems and Single-Room Systems. Both multi-room and single-room systems hold significant significance in the particle therapy market, as they offer unique benefits and cater to diverse healthcare settings and patient populations.

The particle therapy market is segmented into three distinct categories according to the end-users: hospitals, clinics, ambulatory surgery centers, and others. The presence of diverse end-users in this market signifies the extensive acceptance and increasing need for advanced cancer treatment alternatives. This, in turn, propels the growth and advancement of the market within different healthcare settings.

Particle Therapy Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The North America region dominates the market due to the increasing funding and investments by manufacturers, as well as the government's focus on establishing treatment centers. Manufacturers of particle therapy systems and related technologies have made significant investments in research and development to enhance the capabilities and accessibility of particle therapy. According to U.S. Investments in Medical and Health Research and Development, the industry accounted for nearly two-thirds (66%) of U.S. medical and health investment in R&D in 2020, reaching USD161.8 billion. Europe holds the second-largest region for market growth, primarily due to the increasing number of particle therapy centers.

Particle Therapy Market- Competitive Landscape:

The competitive landscape of the particle therapy market is driven by technological advancements. Companies are focused on investing in research and development to enhance the effectiveness, productivity, and safety of their particle therapy systems. Additionally, competition in this market is influenced by market reach and distribution channels. Manufacturers are vying to expand their global footprint by strengthening their sales and service networks, forging alliances with healthcare institutions, and securing agreements for the deployment and upkeep of particle therapy systems. To stay ahead in this fast-paced and ever-changing market, manufacturers and service providers are constantly seeking ways to set themselves apart and gain a competitive advantage.

Recent Developments:

Mevion Medical Systems, a top provider of compact proton therapy systems for cancer patients receiving radiation treatment, has unveiled the establishment of 'Mevion Capital' in the United States and Canada in October 2023.

On June 16, 2023, IBA, a renowned global company specializing in particle accelerator technology and the leading provider of proton therapy solutions for cancer treatment, joined forces with PARTICLE (Particle Therapy Interuniversity Center Leuven). This collaboration aims to establish a Research Partnership dedicated to advancing the development of Conformal FLASH.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PARTICLE THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Danfysik A/S

Hitachi, Ltd.

IBA

Mevion Medical Systems.

Optivus Proton Therapy, Inc.

ProTom International.

Provision Healthcare.

Sumitomo Heavy Industries, Ltd.

Siemens Healthcare GmbH

Others

GLOBAL PARTICLE THERAPY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Proton Therapy
  • Heavy Ion Therapy

GLOBAL PARTICLE THERAPY MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons

GLOBAL PARTICLE THERAPY MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pediatric Cancer
  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Brain and Spinal Cord Cancer
  • Others

GLOBAL PARTICLE THERAPY MARKET, BY SYSTEM- MARKET ANALYSIS, 2019 - 2032

  • Multi-Room Systems
  • Single-Room Systems

GLOBAL PARTICLE THERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospital
  • Clinics
  • Ambulatory Surgery Centers
  • Others

GLOBAL PARTICLE THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Particle Therapy Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Particle Therapy Market Snippet by Product Type
    • 2.1.2.Particle Therapy Market Snippet by Service
    • 2.1.3.Particle Therapy Market Snippet by Cancer Type
    • 2.1.4.Particle Therapy Market Snippet by System
    • 2.1.5.Particle Therapy Market Snippet by End User
    • 2.1.6.Particle Therapy Market Snippet by Country
    • 2.1.7.Particle Therapy Market Snippet by Region
  • 2.2.Competitive Insights

3.Particle Therapy Key Market Trends

  • 3.1.Particle Therapy Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Particle Therapy Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Particle Therapy Market Opportunities
  • 3.4.Particle Therapy Market Future Trends

4.Particle Therapy Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Particle Therapy Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Particle Therapy Market Landscape

  • 6.1.Particle Therapy Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Particle Therapy Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Proton Therapy
    • 7.1.3.Heavy Ion Therapy

8.Particle Therapy Market - By Service

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Service, 2023 & 2032 (%)
    • 8.1.2.Cyclotrons
    • 8.1.3.Synchrotrons
    • 8.1.4.Synchrocyclotrons

9.Particle Therapy Market - By Cancer Type

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
    • 9.1.2.Pediatric Cancer
    • 9.1.3.Prostate Cancer
    • 9.1.4.Lung Cancer
    • 9.1.5.Breast Cancer
    • 9.1.6.Brain and Spinal Cord Cancer
    • 9.1.7.Others

10.Particle Therapy Market - By System

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By System, 2023 & 2032 (%)
    • 10.1.2.Multi-Room Systems
    • 10.1.3.Single-Room Systems

11.Particle Therapy Market - By End User

  • 11.1.Overview
    • 11.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 11.1.2.Hospital
    • 11.1.3.Clinics
    • 11.1.4.Ambulatory Surgery Centers
    • 11.1.5.Others

12.Particle Therapy Market- By Geography

  • 12.1.Introduction
    • 12.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2.North America
    • 12.2.1.Overview
    • 12.2.2.Particle Therapy Key Manufacturers in North America
    • 12.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5.North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.2.6.North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.2.7.North America Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
    • 12.2.8.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9.U.S.
      • 12.2.9.1.Overview
      • 12.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4.U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.9.5.U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.2.9.6.U.S. Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.2.9.7.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10.Canada
      • 12.2.10.1.Overview
      • 12.2.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4.Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.10.5.Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.2.10.6.Canada Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.2.10.7.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3.Europe
    • 12.3.1.Overview
    • 12.3.2.Particle Therapy Key Manufacturers in Europe
    • 12.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5.Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.3.6.Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.3.7.Europe Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
    • 12.3.8.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9.Germany
      • 12.3.9.1.Overview
      • 12.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4.Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.9.5.Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.9.6.Germany Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.9.7.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10.Italy
      • 12.3.10.1.Overview
      • 12.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4.Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.10.5.Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.10.6.Italy Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.10.7.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11.United Kingdom
      • 12.3.11.1.Overview
      • 12.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4.United Kingdom Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.11.5.United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.11.6.United Kingdom Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.11.7.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12.France
      • 12.3.12.1.Overview
      • 12.3.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4.France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.12.5.France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.12.6.France Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.12.7.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13.Russia
      • 12.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.3.Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.13.4.Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5.Russia Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.13.6.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14.Netherlands
      • 12.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.3.Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.14.4.Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5.Netherlands Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.14.6.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15.Sweden
      • 12.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.3.Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.15.4.Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5.Sweden Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.15.6.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16.Poland
      • 12.3.16.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.3.Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.16.4.Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5.Poland Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.16.6.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17.Rest of Europe
      • 12.3.17.1.Overview
      • 12.3.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4.Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.17.5.Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.3.17.6.Rest of the Europe Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.3.17.7.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4.Asia Pacific (APAC)
    • 12.4.1.Overview
    • 12.4.2.Particle Therapy Key Manufacturers in Asia Pacific
    • 12.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5.Asia Pacific Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.4.6.Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.4.7.Asia Pacific Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
    • 12.4.8.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9.India
      • 12.4.9.1.Overview
      • 12.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4.India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.9.5.India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.9.6.India Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.9.7.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10.China
      • 12.4.10.1.Overview
      • 12.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4.China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.10.5.China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.10.6.China Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.10.7.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11.Japan
      • 12.4.11.1.Overview
      • 12.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4.Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.11.5.Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.11.6.Japan Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.11.7.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12.South Korea
      • 12.4.12.1.Overview
      • 12.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4.South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.12.5.South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.12.6.South Korea Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.12.7.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13.Australia
      • 12.4.13.1.Overview
      • 12.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4.Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.13.5.Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.13.6.Australia Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.13.7.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14.Thailand
      • 12.4.14.1.Overview
      • 12.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4.Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.14.5.Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.14.6.Thailand Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.14.7.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15.Indonesia
      • 12.4.15.1.Overview
      • 12.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4.Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.15.5.Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.15.6.Indonesia Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.15.7.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16.Philippines
      • 12.4.16.1.Overview
      • 12.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4.Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.16.5.Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.16.6.Philippines Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.16.7.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17.Rest of APAC
      • 12.4.17.1.Overview
      • 12.4.17.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4.Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.17.5.Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.4.17.6.Rest of APAC Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.4.17.7.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5.Latin America
    • 12.5.1.Overview
    • 12.5.2.Particle Therapy Key Manufacturers in Latin America
    • 12.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5.Latin America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.5.6.Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.5.7.Latin America Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
    • 12.5.8.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9.Brazil
      • 12.5.9.1.Overview
      • 12.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4.Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.9.5.Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.9.6.Brazil Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.5.9.7.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10.Mexico
      • 12.5.10.1.Overview
      • 12.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4.Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.10.5.Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.10.6.Mexico Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.5.10.7.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11.Argentina
      • 12.5.11.1.Overview
      • 12.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4.Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.11.5.Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.11.6.Argentina Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.5.11.7.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12.Colombia
      • 12.5.12.1.Overview
      • 12.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4.Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.12.5.Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.12.6.Colombia Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.5.12.7.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13.Rest of LATAM
      • 12.5.13.1.Overview
      • 12.5.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4.Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.13.5.Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.5.13.6.Rest of LATAM Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.5.13.7.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6.Middle East and Africa
    • 12.6.1.Overview
    • 12.6.2.Particle Therapy Key Manufacturers in Middle East and Africa
    • 12.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5.Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.6.6.Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 12.6.7.Middle East and Africa Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
    • 12.6.8.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9.Saudi Arabia
      • 12.6.9.1.Overview
      • 12.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4.Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.9.5.Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.9.6.Saudi Arabia Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.6.9.7.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10.United Arab Emirates
      • 12.6.10.1.Overview
      • 12.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4.United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.10.5.United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.10.6.United Arab Emirates Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.6.10.7.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11.Israel
      • 12.6.11.1.Overview
      • 12.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4.Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.11.5.Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.11.6.Israel Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.6.11.7.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12.Turkey
      • 12.6.12.1.Overview
      • 12.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4.Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.12.5.Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.12.6.Turkey Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.6.12.7.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13.Algeria
      • 12.6.13.1.Overview
      • 12.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4.Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.13.5.Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.13.6.Algeria Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.6.13.7.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14.Egypt
      • 12.6.14.1.Overview
      • 12.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4.Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.14.5.Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.14.6.Egypt Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.6.14.7.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15.Rest of MEA
      • 12.6.15.1.Overview
      • 12.6.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4.Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.15.5.Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 12.6.15.6.Rest of MEA Market Size and Forecast, By System, 2019 - 2032 (US$ Million)
      • 12.6.15.7.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13.Key Vendor Analysis- Particle Therapy Industry

  • 13.1.Competitive Dashboard
  • 13.2.Company Profiles
    • 13.2.1.Danfysik A/S
    • 13.2.2.Hitachi, Ltd.
    • 13.2.3.IBA
    • 13.2.4.Mevion Medical Systems.
    • 13.2.5.Optivus Proton Therapy, Inc.
    • 13.2.6.ProTom International.
    • 13.2.7.Provision Healthcare.
    • 13.2.8.Sumitomo Heavy Industries, Ltd.
    • 13.2.9.Siemens Healthcare GmbH
    • 13.2.10.Others

14.360 Degree Analyst View

15.Appendix

  • 15.1.Research Methodology
  • 15.2.References
  • 15.3.Abbreviations
  • 15.4.Disclaimer
  • 15.5.Contact Us